Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 4, 2006, Pages 538-544

  Wu, Wei ^a   Yao, Deng Fu ^a   Yuan, Yong Mei ^a   Fan, Ji Wei ^a   Lu, Xiu Feng ^a   Li, Xiao Hua ^a   Qiu, Li Wei ^a   Zong, Lei ^a   Wu, Xin Hua ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Affinity chromatography; AFP mRNA; Carcinoma; Hepatocellular; Hepatoma specific AFP; Immunohistochemistry; RT PCR

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; HEPATOMA SPECIFIC ALPHA FETOPROTEIN; LECTIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; CANCER RELAPSE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; TISSUE LEVEL;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 33751256825     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-988.
2. Kreczko S, Lipska A, Wysocka J. Alfa-fetoprotein: diagnostic value in hepatic disorders. Pol Merkuriusz Lek 2000;8:420-423.
3. Bae JS, Park SJ, Park KB, Paik SY, Ryu JK, Choi CK, et al. Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med 2005;20:80-85.
4. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-3230.
5. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: An overview. Asian Pac J Cancer Prev 2004;5: 118-125.
6. Yu AS, Keeffe EB. Management of hepatocellular carcinoma. Rev Gastroenterol Disord 2003;3:8-24.
7. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002;62:5-7.
8. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001;7:445-445.
9. Omata M, Yoshida H. Resolution of liver cirrhosis and prevention of hepatocellular carcinoma by interferon therapy against chronic hepatitis C. Scand J Gastroenterol Suppl 2003;237:47-53.
10. Johnson PJ. Hepatocellular carcinoma: Is current therapy really altering outcome? Gut 2002;51:459-462.
11. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002;131:S153-158.
12. Kamoto T, Satomura S, Yoshiki T, Okada Y, Henmi F, Nishiyama H, et al. Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors. Jpn J Clin Oncol 2002;32:472-476.
13. Okuno M, Sano T, Matsushima-Nishiwaki R, Adachi S, Akita K, Okano Y, et al. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma. Jpn J Clin Oncol 2001;31:359-362.
14. Morimoto O, Nagano H, Miyamoto A, Fujiwara Y, Kondo M, Yamamoto T, et al. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today 2005;35:1033-1041.
15. Cillo U, Navaglia F, Vitale A, Molari A, Basso D, Bassanello M, et al. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. Clin Chim Acta 2004;347:129-138.
16. Yao DF, Jiang DR, Huang ZW. Abnormal expressiom of hepatoma specific γ-glutamyl transferase and alteration of r-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000;88:761-769.
17. Wong IN, Leung T, Ho S, Lau WY, Chan M, Johnson PJ. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997;76:628-634.
18. Yao DF, Dong ZZ, Yang DM, Zhu YS, Jiang DR, Lu JX. Peripheral blood AFP-mRNA amplification in the diagnosis and differential diagnosis of hepatocellular carcinoma. Chin J Gen Surg 2000;15:474-477.
19. Wu W, Yao DF, Gu LH, Fan JW, Lu XF, Li XH, et al. Determination of hepatoma-specific alpha-fetoprotein by a mini-column affinity chromato- graphy method. Chin J Clin Lab Sci 2006;24:10-12.
20. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. Alpha-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma; a prospective study. Hepatology 2002;35:853-860.
21. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
22. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res 2003;23:1747-1753.
23. Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002;36:410-417.
24. Tang ZY. Hepatocellular carcinoma - cause, treatment and metastasis. World J Gastroenterol 2001;7:445-454.
25. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33: 1080-1086.
26. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-395.
27. Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 2002;62:57-63.
28. Taketa K, Okada S, Win N, Hlaing NK, Wind KM. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar. Acta Med Okayama 2002;56:317-320.
29. Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, et al. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers 2001;16:105-111.
30. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
31. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-507.
32. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-1536.
33. Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol 2003;29:266-271.
34. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 2003;197:753-758.
35. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 2004;28:376-381.
36. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;6:224-232.
37. Cillo U, Vitale A, Navaglia F, Basso D, Montin U, Bassanello M, et al. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma. World J Gastroenterol 2005;11:6920-6925.
38. Takeda S, Nakao A. Genetic detection and clinical applications in patients with hepatocellular carcinoma. Nippon Geka Gakkai Zasshi 2002;103:472-475.
39. Yao F, Guo JM, Xu CF, Lou YL, Xiao BX, Zhou WH, et al. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Clin Chim Acta 2005;361:119-127.
40. Yoshida S, Kurokohchi K, Arima K, Masaki T, Hosomi N, Funaki T, et al. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma. Int J Oncol 2002;20: 305-309.